Crowmie

Crowmie

TBA
1,918 Views
Crowmie, the new way of investing in Renewable Energy was born with a purpose, to accelerate the energy transition. The energy crisis that we are facing in Spain is a reality that we all know. And do you know what the solution is? The only alternative is the Energy Transition through renewable energies, where we still have a lot to do. The energy sector represents one of the largest markets worldwide. In Spain alone, an investment of more than 190 billion euros will be needed for the Energy Transition. It is almost impossible to invest in the sector, it is limited by paperwork and bureaucracy, the transaction costs are high, they are usually high investments and very little liquid… in short, this means that most of us are excluded from investments in the sector. Crowmie was born to solve these problems, it is a revolutionary idea that will give access and provide the necessary tools so that any person, company or entity can participate and accelerate the Energy Transition. How do we do it? Our platform is very simple, we select the asset and then we tokenize a participating loan guaranteeing monthly dividends linked to the performance of the asset. Why do we use tokenization in renewable energy projects? Having a digitized asset has many advantages, including: We democratize investment. Thanks to the value of the tokens (€100), any person, company or entity can invest in the project. Global Access . We eliminate demographic barriers so that anyone from anywhere in the world can invest. The tokens are easily transferable , in seconds and at a very low cost . Only the gas required to execute the transaction on the blockchain (network fee). Liquidity . Thanks to DeFi protocols you can recover your investment at market value at the time you want or you can exchange it to a third party. We thus convert the investment into a liquid investment. Welcome to Crowmie , the new way to invest in renewable energy.
1.1
TOTAL SCORE
1.2
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Dates: TBA
Token info
Ticker: Crowmie
Platform: Binance Chain
Financial
Social media
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
DATA
DATA is a blockchain project initiated and governed by Blockchain Data Foundation Limited ("Blockchain Data Foundation", or BDF from hereafter), a company limited by guarantee to be incorporated in Singapore and governed in a not-for-profit manner. This project is being developed in collaboration with Yomob International Co., Ltd. ("Yomob"), a mobile monetization-as-a-service company.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
Plentix
The advent of cryptocurrencies and the tokenized economy makes it possible to re-imagine the entire value chain of consumer, products, and producers from a referral perspective. We present Plentix, a tokenized platform that enables users to refer other users to a business entity and enables business entities to leverage existing APIs for industry specific referrals and allows for safe, secure, trustless value exchange to take place. Unlike other referral platforms, Plentix unleashes the potential of a new global ecosystem to monetize referrals for every stakeholder, from the producer to the consumer.
Upcoming
Feniks
Feniks.Finance is a new financial blockchain based system, created on a fundamentally new concept, capable of scaling its speed as needed and adding new functionality. Feniks.Finance can be used as an international banking system for information transfer and payment execution. The first version of Feniks.Finance will be able to handle payments and storage of users' funds. Namely, the banking transactions labeled in the SWIFT system with MT103 as payment sent and MT202 as a receipt and crediting of the payment to the account. The next step in the development of the system will be a 700 group of SWIFT operations, namely documentary transactions better known as guarantees and letters of credit. The introduction of the 500 group, that is, the operation with securities, suggests that an exchange will appear in our network.
Upcoming
ECTA
ECTA (Efficient Collaboration Team Autonomous) is the first blockchain-based trust protocol for global employability of developers. The concept, empowered by the proven AI tools, aims to solve the inefficiencies related to the time loss, verification of online profiles, talents discovery (especially in the low-middle income countries) and safe way to conduct business (payment solution with the power of smart contracts). While working on ECTA platform, besides collecting their earnings in ECTA tokens (ERC20) developers are having a unique possibility to earn (mine) ECTA non-fungible tokens (ERC721) as a reward for every task completed - which serve as proof of their skills and increase their reputation. AI component of the platform helps companies worldwide discover and employ these developers in a safe and productive way for both sides.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.